Mikanolide enhances tobacco TMV resistance by strengthening cell walls via EXP/PG repression and activating defense via LYKs.

Taijiao Yang,Wei Zhang,Jinkang Qi,Jinfang Li,Zhuoqing Zhang,Ming Tian,Qing Li,Shijun Hu,Xiaohui Yan

Published 2025 in Pesticide Biochemistry and Physiology

ABSTRACT

Tobacco mosaic virus (TMV) is a major pathogen of Solanaceae, threatening tobacco yield and quality. In this study, 12 compounds from Mikania micrantha were evaluated for their inhibitory effects on TMV using the half-leaf method and ID-ELISA assay. Compound 1 (Mikanolide) showed superior protective (63.43 %) and therapeutic (69.09 %) activities compared to other compounds and Ningnanmycin. It also exhibited inactivation (50.98 %) and proliferation inhibition (60.64 %) against TMV. Molecular docking revealed its binding to TMV-CP through hydrogen and hydrophobic bonds. Mechanistic analyses indicated that Mikanolide elevated chlorophyll contents, flavonoid and total phenol biosynthesis, and salicylic acid accumulation, thereby enhancing defense-related enzymatic activity. Transcriptome analyses showed increased expression of cell wall-related EXP and PG genes, as well as LYKs defense response genes, while suppressing LRR protein 66, Hsc70, BTB/POZ-TAZ, polygalacturonase, and expansins, indicating maintenance of cell wall integrity during TMV infection. RT-qPCR confirmed these results. In conclusion, Mikanolide enhances tobacco's resistance to TMV by inhibiting viral replication and proliferation and activating the plant's disease resistance signaling.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-62 of 62 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1